Y. YILMAZ, "Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis," Alimentary Pharmacology and Therapeutics , vol.60, no.7, pp.974-975, 2024
YILMAZ, Y. 2024. Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis. Alimentary Pharmacology and Therapeutics , vol.60, no.7 , 974-975.
YILMAZ, Y., (2024). Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis. Alimentary Pharmacology and Therapeutics , vol.60, no.7, 974-975.
YILMAZ, YUSUF. "Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis," Alimentary Pharmacology and Therapeutics , vol.60, no.7, 974-975, 2024
YILMAZ, YUSUF. "Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis." Alimentary Pharmacology and Therapeutics , vol.60, no.7, pp.974-975, 2024
YILMAZ, Y. (2024) . "Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis." Alimentary Pharmacology and Therapeutics , vol.60, no.7, pp.974-975.
@article{article, author={YUSUF YILMAZ}, title={Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis}, journal={Alimentary Pharmacology and Therapeutics}, year=2024, pages={974-975} }